A group of Democratic lawmakers is calling for the Trump administration to suspend a new surveillance program it quietly launched to collect the personal and identifiable health data of Americans who visit emergency rooms.
KFF Health News first reported that the Consumer Product Safety Commission — a federal agency tasked with monitoring injuries from household items — was pressuring hospitals to provide a private company with personally identifiable health information for analysis. The rollout of the program has inspired broad pushback from hospitals and privacy advocates.
The CPSC’s goal is to obtain millions of Americans’ medical records from emergency rooms for most injuries, even when a consumer product is not involved, internal emails and documents reviewed by KFF Health News revealed. The agency instructed hospitals to share detailed patient information for more than 10,000 types of injuries or conditions, such as vaccine reactions, suicide attempts, or stingray stabs.
The scope of data CPSC is collecting far exceeds the agency’s mission and should be immediately suspended, Massachusetts Sen. Ed Markey, who sits on the Senate Health, Education, Labor, and Pensions Committee, and other House and Senate Democrats wrote in a letter to CPSC acting Chairman Peter Feldman.
“This unprecedented and sweeping effort to collect identifiable patient data is untethered from the Commission’s statutory mission and authority, and is ripe for misuse by an administration that has repeatedly sought access to Americans’ most personal information,” the letter stated. “Americans should be able to seek medical care without fear that their personal health information will be swept into a federal database and repurposed for political ends.”
Among other Democrats signing the letter were Sen. Richard Blumenthal of Connecticut, Rep. Jan Schakowsky of Illinois, and Sen. Ron Wyden of Oregon, the ranking member of the Senate Finance Committee.
CPSC spokesperson Steve Roney did not answer several questions about the program and the call for it to be suspended.
“We received the letter, and will respond directly, through the appropriate channels,” he said in a statement.
The CPSC is one of several agencies that have launched broad acquisitions of Americans’ sensitive medical records during Trump’s second term. The Office of Personnel Management has requested federal workers’ sensitive health information. Health and Human Services Secretary Robert F. Kennedy Jr. deputized at least one private organization to collect more medical records for his studies on vaccines and autism.
The CPSC has operated a voluntary program for decades that enables trained hospital workers based in about 70 hospitals nationwide to report injuries involving consumer products, called the National Electronic Injury Surveillance System, or NEISS. Compared with the current initiative, the agency’s data collection has historically been far narrower, and previously requested patients’ identifiable information, generally for follow-up, in fewer than 1% of cases.
Without public notice, CPSC staffers overhauled the program early this year — rebranding it as NEISS-R — and told hospital executives that participation is mandatory, requiring they report far more identifiable patient details from more injuries to a private company called Konza Health. The Kansas-based company won a five-year contract last year worth up to $15.9 million with the CPSC.
In emails and contract language reviewed by KFF Health News, Konza representatives described hospital participation as “mandatory” or “required.” Emails sent this year by CPSC chief data officer Elizabeth Puchek said hospitals would need to apply for an exemption from participation or face penalties. Those penalties, for what’s called unlawful “information blocking,” were established in a federal data-sharing regulation designed to make sure patients could access their medical records. The agency’s website reiterated that threat, claiming information-blocking regulations require hospitals “to make electronic health information (EHI) available to public health authorities, such as CPSC, upon request, unless a specific exception applies.”
The power play inspired widespread resistance. The American Hospital Association sent a letter in August asking for modifications to the program, citing “confusion and concern about the scope of patient information” demanded by the agency.
Now the agency is backtracking, removing in recent weeks mentions of “information blocking” penalties from its public page.
The CPSC’s Feldman, a Trump appointee, said in an interview last month with Nextgov/FCW that the new program would “remain a voluntary” one.
The Democrats highlighted these discrepancies and changes, also noting that the agency has bypassed regulations and failed to publicly lay out any detailed plan for its data collection, as required by law.
“The Commission has since quietly removed the information blocking rationale from its public NEISS webpage, without any public correction or acknowledgment that the claim it spent months promoting was without basis,” the letter said. “This reversal does not undo the coercion hospitals experienced, but rather raises the question of whether the Commission’s purported legal justifications were ever more than post-hoc cover for an agenda that had little to do with its statutory authority.” The Democrats’ letter asks CPSC to respond by Sept. 18.
Facts Only
* Democratic lawmakers called for the Trump administration to suspend a surveillance program.
* The program collects personal and identifiable health data of Americans visiting emergency rooms.
* The Consumer Product Safety Commission (CPSC) pressured hospitals to provide personally identifiable health information to a private company for analysis.
* The data collected included details on over 10,000 types of injuries or conditions (e.g., vaccine reactions, suicide attempts).
* Massachusetts Sen. Ed Markey and other Democrats wrote to the CPSC acting Chairman Peter Feldman urging suspension.
* The lawmakers stated the effort was untethered from the Commission’s statutory mission and risked misuse of personal health information for political ends.
* The CPSC previously operated the National Electronic Injury Surveillance System (NEISS) voluntarily, collecting narrower data historically.
* CPSC staffers overhauled the program and made hospital participation mandatory, requiring reporting on more identifiable details to Konza Health.
* Penalties for "information blocking" were established in federal regulations intended to protect patient records.
* The CPSC later removed mentions of "information blocking" penalties from its public webpage.
Executive Summary
Democratic lawmakers are calling for the Trump administration to suspend a surveillance program that collects personally identifiable health data from Americans visiting emergency rooms. This action is based on concerns that the program exceeds the Consumer Product Safety Commission’s statutory mission and risks misuse of personal health information by the administration. The program was initiated when the CPSC pressured hospitals to share patient data for analysis, including details about injuries such as vaccine reactions or suicide attempts.
The pushback came from hospitals and privacy advocates, who argued that collecting this sensitive information is untethered from the agency's authority. Democrats signed a letter to the CPSC acting Chairman demanding suspension, asserting that Americans should be able to seek medical care without fear of having their health data repurposed for political ends.
The CPSC previously operated a voluntary system called NEISS, which historically collected much less identifiable patient information. The program was overhauled by the agency and mandated hospital participation, requiring reporting on more injuries to a private company, Konza Health. The controversy intensified when the agency quietly removed references to "information blocking" penalties from its public page despite previous claims regarding these regulations.
Full Take
The narrative structure reveals a friction between agency mandate, public trust, and executive authority regarding data collection. The core tension lies between an agency’s stated regulatory function (monitoring consumer product injuries) and the expansion of its data scope into sensitive private health information, suggesting a potential mission drift. The pattern where external political actors use procedural discrepancies—such as removing penalty references or disputing voluntary status—to challenge established authority points to a strategy where technical legality is leveraged to mask substantive overreach. The move from a voluntary system (NEISS) to a mandatory data transfer suggests a shift from public safety monitoring to private commercial exploitation, which inherently raises questions about data governance and privacy safeguards. The fact that the agency backtracked on its claims regarding "information blocking" penalties without public correction implies an attempt to manage liability rather than address legitimate concerns regarding coercion experienced by institutions. The implication for human agency is that access to healthcare information is not purely a matter of statutory authority but is deeply contingent on the perceived transparency and ethical scope of the collecting bodies, regardless of the immediate legal justifications employed.
Bridge Questions: If data collection mechanisms are technically lawful under existing statutes, what specific regulatory framework should be established to govern the intersection of consumer safety oversight and personal medical data? What independent auditing mechanism could ensure that agency mandates remain tethered to their original statutory missions when expanding data scope? How can institutions build trust when processes involving mandatory data sharing appear designed to benefit external entities rather than serve public health goals?
Sentinel — Human
The text reads as an analytical journalistic piece that synthesizes specific claims and evidence to build an argument regarding government data collection practices.